Anti-GBA antibody [EPR5143(3)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
3
(4 Reviews)
|
(10 Publications)
Rabbit Recombinant Monoclonal GBA antibody. Suitable for IHC-P, WB and reacts with Human, Rat samples. Cited in 10 publications.
View Alternative Names
GBA, GC, GLUC, GBA1, Lysosomal acid glucosylceramidase, Lysosomal acid GCase, Acid beta-glucosidase, Alglucerase, Beta-glucocerebrosidase, Beta-glucosylceramidase 1, Cholesterol glucosyltransferase, Cholesteryl-beta-glucosidase, D-glucosyl-N-acylsphingosine glucohydrolase, Glucosylceramidase beta 1, Imiglucerase, Lysosomal cholesterol glycosyltransferase, Lysosomal galactosylceramidase, Lysosomal glycosylceramidase, Beta-GC, SGTase
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)
ab128879, unpurified, at a 1/100 dilution, staining GBA in paraffin embedded Human kidney tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)
ab128879, unpurified, at a 1/100 dilution, staining GBA in paraffin embedded Human thyroid carcinoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)
ab128879 staining GBA in Human kidney tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed and paraffin-embedded, antigen retrieval was by heat mediation in Tris/EDTA buffer pH9. Samples were incubated with primary antibody (1/200). An undiluted HRP-conjugated anti-rabbit IgG was used as the secondary antibody. Tissue counterstained with Hematoxylin.
- WB
Lab
Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
Lanes 1 - 4 : Merged signal (red and green). Green - ab128879 observed at 60 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab128879 was shown to specifically react with GBA in wild-type HAP1 cells as well as additional cross reactive bands. No bands were observed when GBA knockout samples were used. Wild-type and GBA knockout samples were subjected to SDS-PAGE. ab128879 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/10,000 dilution respectively. Blots were developed with 800CW Goat anti-Rabbit and 680CW Goat anti-Mouse secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
GBA knockout HAP1 whole cell lysate at 20 µg
Lane 3:
MCF7 whole cell lysate at 20 µg
Lane 4:
HepG2 whole cell lysate at 20 µg
Predicted band size: 60 kDa
false
- WB
Lab
Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
Lanes 1- 2 : Merged signal (red and green). Green - ab128879 observed at 60 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab128879 was shown to react with GBA in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265038 (knockout cell lysate ab256929) was used. Wild-type HeLa and GBA knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab128879 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
GBA knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human GBA knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-gba-knockout-hela-cell-line-ab265038'>ab265038</a>)
Predicted band size: 60 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
All lanes:
Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/4000 dilution
Lane 1:
Saos-2 Cell Lysate at 20 µg
Lane 2:
U87-MG Cell Lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), HRP- conjugated at 1/1000 dilution
Predicted band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
All lanes:
Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/1000 dilution
Lane 1:
293T cell lysate at 10 µg
Lane 2:
Saos-2 cell lysate at 10 µg
Lane 3:
U87-MG cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
Blocking and diluting buffers :
Lane 1 and 2 : 5% NFDM/TBST
Lane 3 and 4 : 2% BSA/TBST
We suggest using 2% BSA/TBST as blocking buffer and antibody diluting buffer if you cannot obtain strong band in some samples.
Lane 1:
Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/10000 dilution
Lanes 2 - 4:
Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/50000 dilution
All lanes:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/100000 dilution
Predicted band size: 60 kDa
Observed band size: 60 kDa
false
Exposure time: 180s
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-GBA antibody [EPR5143(3)] (AB128879)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (3)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-GBA antibody [EPR5143(3)]
-
Anti-GBA antibody [EPR5143(3)] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-GBA antibody [EPR5143(3)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GBA plays an important role in sphingolipid metabolism. It participates in the degradation of glycolipids within the lysosome contributing to lipid recycling. It acts independently rather than as a part of a major enzymatic complex. Through its role in degrading glucosylceramide GBA influences cellular homeostasis and bioenergetics ensuring balance in neural and systemic lipid levels.
Pathways
GBA’s enzymatic functions are integral to the glycosphingolipid metabolic pathway. It is involved in the downstream steps of the lysosomal degradation of glycosphingolipids. The pathway operates alongside other important proteins such as beta-glucosidase and CERT-related transfer proteins all of which contribute to membrane lipid organization and signal transduction processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Aging cell 23:e14077 PubMed38303548
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Parkinson's disease 14:65-78 PubMed38251062
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:5804 PubMed37726325
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:2057 PubMed37045813
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular neuroscience : MN 72:2313-2325 PubMed36152140
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 19: PubMed30308956
2018
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 32:5685-5702 PubMed29746165
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:12702 PubMed28983119
2017
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of aging 36:2649-59 PubMed26149921
2015
Applications
WB
Species
Cynomolgus monkey
Clinical cardiology 11:311-6 PubMed2898311
1988
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com